nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—MAOB—Parkinson's disease	0.345	0.408	CbGaD
Tranylcypromine—MAOA—Parkinson's disease	0.242	0.286	CbGaD
Tranylcypromine—CYP2E1—Parkinson's disease	0.149	0.177	CbGaD
Tranylcypromine—CYP2D6—Parkinson's disease	0.11	0.13	CbGaD
Tranylcypromine—MAOA—locus ceruleus—Parkinson's disease	0.00441	0.175	CbGeAlD
Tranylcypromine—MAOB—nerve—Parkinson's disease	0.00155	0.0614	CbGeAlD
Tranylcypromine—MAOA—nerve—Parkinson's disease	0.00132	0.0524	CbGeAlD
Tranylcypromine—Fencamfamine—SLC6A3—Parkinson's disease	0.0012	0.16	CrCbGaD
Tranylcypromine—MAOB—hindbrain—Parkinson's disease	0.00116	0.046	CbGeAlD
Tranylcypromine—MAOA—hindbrain—Parkinson's disease	0.000988	0.0392	CbGeAlD
Tranylcypromine—Phenmetrazine—SLC6A3—Parkinson's disease	0.00074	0.0987	CrCbGaD
Tranylcypromine—MAOB—embryo—Parkinson's disease	0.000724	0.0287	CbGeAlD
Tranylcypromine—MAOB—brainstem—Parkinson's disease	0.000664	0.0263	CbGeAlD
Tranylcypromine—MAOB—forebrain—Parkinson's disease	0.000641	0.0254	CbGeAlD
Tranylcypromine—MAOA—embryo—Parkinson's disease	0.000618	0.0245	CbGeAlD
Tranylcypromine—Phendimetrazine—SLC6A3—Parkinson's disease	0.000613	0.0818	CrCbGaD
Tranylcypromine—CYP2D6—hindbrain—Parkinson's disease	0.000587	0.0233	CbGeAlD
Tranylcypromine—MAOA—brainstem—Parkinson's disease	0.000566	0.0225	CbGeAlD
Tranylcypromine—Dextroamphetamine—SLC18A2—Parkinson's disease	0.00055	0.0735	CrCbGaD
Tranylcypromine—MAOA—forebrain—Parkinson's disease	0.000547	0.0217	CbGeAlD
Tranylcypromine—MAOB—cardiovascular system—Parkinson's disease	0.000542	0.0215	CbGeAlD
Tranylcypromine—MAOB—medulla oblongata—Parkinson's disease	0.000463	0.0184	CbGeAlD
Tranylcypromine—MAOA—cardiovascular system—Parkinson's disease	0.000462	0.0183	CbGeAlD
Tranylcypromine—Amphetamine—SLC18A2—Parkinson's disease	0.000444	0.0592	CrCbGaD
Tranylcypromine—CYP2A6—cerebellum—Parkinson's disease	0.000444	0.0176	CbGeAlD
Tranylcypromine—MAOB—midbrain—Parkinson's disease	0.000423	0.0168	CbGeAlD
Tranylcypromine—MAOB—spinal cord—Parkinson's disease	0.000413	0.0164	CbGeAlD
Tranylcypromine—Phentermine—MAOB—Parkinson's disease	0.000396	0.0528	CrCbGaD
Tranylcypromine—MAOA—medulla oblongata—Parkinson's disease	0.000395	0.0157	CbGeAlD
Tranylcypromine—MAOB—head—Parkinson's disease	0.000367	0.0146	CbGeAlD
Tranylcypromine—CYP2C9—cardiovascular system—Parkinson's disease	0.000366	0.0145	CbGeAlD
Tranylcypromine—MAOA—midbrain—Parkinson's disease	0.000361	0.0143	CbGeAlD
Tranylcypromine—CYP2A6—brain—Parkinson's disease	0.00036	0.0143	CbGeAlD
Tranylcypromine—MAOA—spinal cord—Parkinson's disease	0.000352	0.014	CbGeAlD
Tranylcypromine—MAOB—nervous system—Parkinson's disease	0.000348	0.0138	CbGeAlD
Tranylcypromine—CYP2E1—cardiovascular system—Parkinson's disease	0.000347	0.0138	CbGeAlD
Tranylcypromine—CYP2D6—brainstem—Parkinson's disease	0.000337	0.0134	CbGeAlD
Tranylcypromine—MAOB—central nervous system—Parkinson's disease	0.000335	0.0133	CbGeAlD
Tranylcypromine—MAOB—cerebellum—Parkinson's disease	0.000327	0.013	CbGeAlD
Tranylcypromine—CYP2D6—forebrain—Parkinson's disease	0.000325	0.0129	CbGeAlD
Tranylcypromine—Phenelzine—MAOB—Parkinson's disease	0.000323	0.0431	CrCbGaD
Tranylcypromine—MAOA—head—Parkinson's disease	0.000313	0.0124	CbGeAlD
Tranylcypromine—Phenylpropanolamine—MAOA—Parkinson's disease	0.000311	0.0416	CrCbGaD
Tranylcypromine—Amphetamine—MAOB—Parkinson's disease	0.000304	0.0406	CrCbGaD
Tranylcypromine—MAOA—nervous system—Parkinson's disease	0.000297	0.0118	CbGeAlD
Tranylcypromine—CYP2E1—medulla oblongata—Parkinson's disease	0.000296	0.0118	CbGeAlD
Tranylcypromine—MAOA—central nervous system—Parkinson's disease	0.000286	0.0113	CbGeAlD
Tranylcypromine—Phenylpropanolamine—DRD1—Parkinson's disease	0.000283	0.0378	CrCbGaD
Tranylcypromine—MAOA—cerebellum—Parkinson's disease	0.000279	0.0111	CbGeAlD
Tranylcypromine—Phentermine—MAOA—Parkinson's disease	0.000278	0.037	CrCbGaD
Tranylcypromine—Phenylpropanolamine—SLC6A3—Parkinson's disease	0.000269	0.0358	CrCbGaD
Tranylcypromine—MAOB—brain—Parkinson's disease	0.000266	0.0105	CbGeAlD
Tranylcypromine—CYP2E1—spinal cord—Parkinson's disease	0.000264	0.0105	CbGeAlD
Tranylcypromine—Phentermine—SLC6A3—Parkinson's disease	0.000239	0.0319	CrCbGaD
Tranylcypromine—CYP2E1—head—Parkinson's disease	0.000235	0.00932	CbGeAlD
Tranylcypromine—Dextroamphetamine—SLC6A3—Parkinson's disease	0.000228	0.0305	CrCbGaD
Tranylcypromine—MAOA—brain—Parkinson's disease	0.000227	0.009	CbGeAlD
Tranylcypromine—Phenelzine—MAOA—Parkinson's disease	0.000226	0.0302	CrCbGaD
Tranylcypromine—CYP2E1—nervous system—Parkinson's disease	0.000223	0.00884	CbGeAlD
Tranylcypromine—CYP2E1—central nervous system—Parkinson's disease	0.000214	0.00851	CbGeAlD
Tranylcypromine—CYP2E1—cerebellum—Parkinson's disease	0.00021	0.00832	CbGeAlD
Tranylcypromine—CYP2D6—head—Parkinson's disease	0.000186	0.00738	CbGeAlD
Tranylcypromine—Amphetamine—SLC6A3—Parkinson's disease	0.000184	0.0246	CrCbGaD
Tranylcypromine—CYP3A4—nervous system—Parkinson's disease	0.000179	0.00711	CbGeAlD
Tranylcypromine—CYP2D6—nervous system—Parkinson's disease	0.000176	0.007	CbGeAlD
Tranylcypromine—CYP3A4—central nervous system—Parkinson's disease	0.000173	0.00685	CbGeAlD
Tranylcypromine—CYP2E1—brain—Parkinson's disease	0.00017	0.00675	CbGeAlD
Tranylcypromine—CYP2D6—central nervous system—Parkinson's disease	0.00017	0.00674	CbGeAlD
Tranylcypromine—CYP2D6—cerebellum—Parkinson's disease	0.000166	0.00658	CbGeAlD
Tranylcypromine—Benzyl alcohol—CYP2E1—Parkinson's disease	0.000165	0.022	CrCbGaD
Tranylcypromine—Phenelzine—CYP2E1—Parkinson's disease	0.00014	0.0186	CrCbGaD
Tranylcypromine—Amphetamine—DRD2—Parkinson's disease	0.000137	0.0183	CrCbGaD
Tranylcypromine—CYP2D6—brain—Parkinson's disease	0.000135	0.00535	CbGeAlD
Tranylcypromine—Phentermine—CYP2D6—Parkinson's disease	0.000126	0.0168	CrCbGaD
Tranylcypromine—Benzyl alcohol—CYP2D6—Parkinson's disease	0.000121	0.0162	CrCbGaD
Tranylcypromine—Dextroamphetamine—CYP2D6—Parkinson's disease	0.00012	0.016	CrCbGaD
Tranylcypromine—Amphetamine—CYP2D6—Parkinson's disease	9.67e-05	0.0129	CrCbGaD
Tranylcypromine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	3.47e-05	0.000288	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	3.45e-05	0.000286	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	3.43e-05	0.000284	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—DDC—Parkinson's disease	3.42e-05	0.000283	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP2D6—Parkinson's disease	3.41e-05	0.000283	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	3.36e-05	0.000279	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CTGF—Parkinson's disease	3.35e-05	0.000277	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	3.26e-05	0.00027	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTA4—Parkinson's disease	3.23e-05	0.000268	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.21e-05	0.000266	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GCH1—Parkinson's disease	3.21e-05	0.000266	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	3.2e-05	0.000265	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	3.16e-05	0.000261	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYP2E1—Parkinson's disease	3.12e-05	0.000258	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.09e-05	0.000256	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NQO1—Parkinson's disease	3.09e-05	0.000256	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—TH—Parkinson's disease	3.04e-05	0.000252	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CYCS—Parkinson's disease	2.92e-05	0.000242	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	2.91e-05	0.000241	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ND3—Parkinson's disease	2.91e-05	0.000241	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PLA2G6—Parkinson's disease	2.91e-05	0.000241	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.88e-05	0.000239	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—MAOB—Parkinson's disease	2.88e-05	0.000239	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—DBH—Parkinson's disease	2.86e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—FBP1—Parkinson's disease	2.86e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GBA—Parkinson's disease	2.86e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.82e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	2.74e-05	0.000227	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—OMD—Parkinson's disease	2.74e-05	0.000227	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.7e-05	0.000224	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.69e-05	0.000223	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.68e-05	0.000222	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.68e-05	0.000222	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ND3—Parkinson's disease	2.68e-05	0.000222	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.66e-05	0.000221	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—DDC—Parkinson's disease	2.66e-05	0.00022	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	2.66e-05	0.00022	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ND3—Parkinson's disease	2.66e-05	0.00022	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.65e-05	0.00022	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	2.6e-05	0.000215	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—COMT—Parkinson's disease	2.59e-05	0.000214	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTP1—Parkinson's disease	2.57e-05	0.000213	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—MAOA—Parkinson's disease	2.57e-05	0.000213	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—HMOX1—Parkinson's disease	2.54e-05	0.00021	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—OMD—Parkinson's disease	2.52e-05	0.000209	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	2.52e-05	0.000209	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTA4—Parkinson's disease	2.51e-05	0.000208	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	2.5e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—OMD—Parkinson's disease	2.5e-05	0.000207	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GCH1—Parkinson's disease	2.48e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	2.47e-05	0.000205	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—ABCB1—Parkinson's disease	2.44e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	2.44e-05	0.000202	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	2.41e-05	0.0002	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	2.39e-05	0.000198	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	2.37e-05	0.000196	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTM1—Parkinson's disease	2.36e-05	0.000196	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GCH1—Parkinson's disease	2.28e-05	0.000189	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ND3—Parkinson's disease	2.27e-05	0.000188	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	2.27e-05	0.000188	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GPX1—Parkinson's disease	2.26e-05	0.000188	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	2.26e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GCH1—Parkinson's disease	2.26e-05	0.000187	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MAOB—Parkinson's disease	2.24e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.23e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.21e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GBA—Parkinson's disease	2.21e-05	0.000183	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—DBH—Parkinson's disease	2.21e-05	0.000183	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP2D6—Parkinson's disease	2.14e-05	0.000177	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	2.13e-05	0.000177	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—OMD—Parkinson's disease	2.13e-05	0.000177	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CTGF—Parkinson's disease	2.1e-05	0.000174	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—DDC—Parkinson's disease	2.1e-05	0.000174	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—MTHFR—Parkinson's disease	2.09e-05	0.000173	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.04e-05	0.000169	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—DBH—Parkinson's disease	2.03e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GBA—Parkinson's disease	2.03e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.03e-05	0.000168	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	2.02e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GBA—Parkinson's disease	2.01e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.01e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—DBH—Parkinson's disease	2.01e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTA4—Parkinson's disease	1.98e-05	0.000164	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYP2E1—Parkinson's disease	1.96e-05	0.000162	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—APOE—Parkinson's disease	1.95e-05	0.000161	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NQO1—Parkinson's disease	1.94e-05	0.00016	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GCH1—Parkinson's disease	1.93e-05	0.00016	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TH—Parkinson's disease	1.91e-05	0.000158	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CYCS—Parkinson's disease	1.83e-05	0.000152	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	1.79e-05	0.000148	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MAOB—Parkinson's disease	1.77e-05	0.000146	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.75e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.75e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	1.74e-05	0.000144	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GBA—Parkinson's disease	1.72e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—FBP1—Parkinson's disease	1.72e-05	0.000142	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—DBH—Parkinson's disease	1.72e-05	0.000142	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—INS—Parkinson's disease	1.66e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	1.66e-05	0.000138	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.65e-05	0.000136	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—OMD—Parkinson's disease	1.65e-05	0.000136	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CTGF—Parkinson's disease	1.63e-05	0.000135	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—COMT—Parkinson's disease	1.62e-05	0.000134	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—DDC—Parkinson's disease	1.62e-05	0.000134	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTP1—Parkinson's disease	1.61e-05	0.000134	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—HMOX1—Parkinson's disease	1.59e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.56e-05	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.53e-05	0.000127	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ABCB1—Parkinson's disease	1.53e-05	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	1.52e-05	0.000126	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.51e-05	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NQO1—Parkinson's disease	1.5e-05	0.000124	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.49e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.49e-05	0.000123	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTM1—Parkinson's disease	1.48e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TH—Parkinson's disease	1.48e-05	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—DDC—Parkinson's disease	1.48e-05	0.000122	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYCS—Parkinson's disease	1.42e-05	0.000118	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GPX1—Parkinson's disease	1.42e-05	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.41e-05	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.39e-05	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.38e-05	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.38e-05	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.36e-05	0.000113	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.33e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.33e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.33e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.31e-05	0.000109	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—MTHFR—Parkinson's disease	1.31e-05	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.3e-05	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.29e-05	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.27e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—DDC—Parkinson's disease	1.26e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—COMT—Parkinson's disease	1.26e-05	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.26e-05	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.25e-05	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTP1—Parkinson's disease	1.25e-05	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MAOA—Parkinson's disease	1.25e-05	0.000104	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.24e-05	0.000103	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HMOX1—Parkinson's disease	1.24e-05	0.000102	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—APOE—Parkinson's disease	1.22e-05	0.000101	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.19e-05	9.87e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.19e-05	9.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCB1—Parkinson's disease	1.19e-05	9.83e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.18e-05	9.8e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.18e-05	9.75e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TH—Parkinson's disease	1.17e-05	9.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—Parkinson's disease	1.15e-05	9.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.12e-05	9.31e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GPX1—Parkinson's disease	1.1e-05	9.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.07e-05	8.89e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.06e-05	8.8e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—INS—Parkinson's disease	1.04e-05	8.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—Parkinson's disease	1.02e-05	8.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.01e-05	8.39e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.01e-05	8.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—COMT—Parkinson's disease	9.95e-06	8.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CTGF—Parkinson's disease	9.95e-06	8.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—Parkinson's disease	9.91e-06	8.21e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MAOA—Parkinson's disease	9.88e-06	8.19e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HMOX1—Parkinson's disease	9.77e-06	8.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—DDC—Parkinson's disease	9.74e-06	8.07e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—APOE—Parkinson's disease	9.48e-06	7.85e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCB1—Parkinson's disease	9.38e-06	7.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	9.27e-06	7.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	9.24e-06	7.65e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	9.2e-06	7.62e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NQO1—Parkinson's disease	9.16e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CTGF—Parkinson's disease	9.15e-06	7.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—Parkinson's disease	9.1e-06	7.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CTGF—Parkinson's disease	9.07e-06	7.51e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TH—Parkinson's disease	9.03e-06	7.48e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GPX1—Parkinson's disease	8.72e-06	7.22e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYCS—Parkinson's disease	8.67e-06	7.18e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	8.52e-06	7.06e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	8.45e-06	7e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NQO1—Parkinson's disease	8.43e-06	6.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NQO1—Parkinson's disease	8.36e-06	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TH—Parkinson's disease	8.31e-06	6.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	8.28e-06	6.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TH—Parkinson's disease	8.24e-06	6.82e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MAOB—Parkinson's disease	8.2e-06	6.79e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—INS—Parkinson's disease	8.1e-06	6.71e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—Parkinson's disease	8.05e-06	6.66e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.98e-06	6.61e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYCS—Parkinson's disease	7.91e-06	6.55e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	7.9e-06	6.54e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CTGF—Parkinson's disease	7.75e-06	6.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—COMT—Parkinson's disease	7.68e-06	6.36e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	7.64e-06	6.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MAOA—Parkinson's disease	7.63e-06	6.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	7.54e-06	6.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—APOE—Parkinson's disease	7.49e-06	6.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	7.23e-06	5.99e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	7.22e-06	5.98e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NQO1—Parkinson's disease	7.14e-06	5.91e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—COMT—Parkinson's disease	7.06e-06	5.85e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TH—Parkinson's disease	7.04e-06	5.83e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	7.03e-06	5.82e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	7.02e-06	5.82e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MAOA—Parkinson's disease	7.01e-06	5.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—COMT—Parkinson's disease	7e-06	5.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	6.97e-06	5.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MAOA—Parkinson's disease	6.95e-06	5.76e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.93e-06	5.74e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	6.87e-06	5.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYCS—Parkinson's disease	6.76e-06	5.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPX1—Parkinson's disease	6.73e-06	5.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.65e-06	5.51e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	6.6e-06	5.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	6.46e-06	5.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	6.4e-06	5.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—INS—Parkinson's disease	6.4e-06	5.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	6.21e-06	5.14e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPX1—Parkinson's disease	6.19e-06	5.12e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPX1—Parkinson's disease	6.13e-06	5.08e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	6.09e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—COMT—Parkinson's disease	5.98e-06	4.96e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.98e-06	4.95e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.96e-06	4.93e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.94e-06	4.92e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	5.87e-06	4.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—APOE—Parkinson's disease	5.78e-06	4.79e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.71e-06	4.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	5.66e-06	4.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.64e-06	4.67e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.57e-06	4.62e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.51e-06	4.56e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	5.47e-06	4.53e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TH—Parkinson's disease	5.43e-06	4.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—APOE—Parkinson's disease	5.32e-06	4.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—APOE—Parkinson's disease	5.27e-06	4.36e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPX1—Parkinson's disease	5.24e-06	4.34e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYCS—Parkinson's disease	5.21e-06	4.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—INS—Parkinson's disease	4.94e-06	4.09e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.84e-06	4.01e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—COMT—Parkinson's disease	4.62e-06	3.82e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.6e-06	3.81e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.59e-06	3.8e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—INS—Parkinson's disease	4.54e-06	3.76e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.53e-06	3.75e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—APOE—Parkinson's disease	4.5e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—INS—Parkinson's disease	4.5e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.35e-06	3.6e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4.22e-06	3.5e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPX1—Parkinson's disease	4.04e-06	3.35e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—INS—Parkinson's disease	3.85e-06	3.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.73e-06	3.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—APOE—Parkinson's disease	3.48e-06	2.88e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—INS—Parkinson's disease	2.97e-06	2.46e-05	CbGpPWpGaD
